Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Casey C, Kopczynski"'
Autor:
Michael A, Singer, David S, Boyer, Stuart, Williams, Hayley, McKee, Kevin, Kerr, Tyler, Pegoraro, Leo, Trevino, Casey C, Kopczynski, David A, Hollander
Publikováno v:
Retina. 43:25-33
AR-1105 is a novel biodegradable sustained-release dexamethasone implant designed to deliver 6-month durability. This Phase 2 study evaluated two AR-1105 formulations with different release profiles in patients with macular edema due to retinal vein
Autor:
Tyler Bagué, Ayushi Singh, Rajanya Ghosh, Hannah Yoo, Curtis Kelly, Mitchell A. deLong, Casey C. Kopczynski, Samuel Herberg
Publikováno v:
Frontiers in Ophthalmology. 2
Interactions between trabecular meshwork (TM) cells and their extracellular matrix (ECM) are critical for normal outflow function in the healthy eye. Multifactorial dysregulation of the TM is the principal cause of elevated intraocular pressure that
Autor:
Albert S. Khouri, Janet B. Serle, Jason Bacharach, Dale W. Usner, Richard A. Lewis, Puiwah Braswell, Casey C. Kopczynski, Theresa Heah, Robert Benza, John W. Boyle, Michelle Butler, Leonard Robert Cacioppo, Jose F. Cardona, Valerie A. Colborn, Douglas G. Day, David T. Douglass, Sherif M. El-Harazi, Deepta Ghate, Carl Hartman, Robert F. Haverly, Barry Katzman, Max Kim, Edward Y. Koo, Michael S. Korenfeld, Bradley Kwapiszeski, Lydia Lane, Christopher Lin, Andrew Gardner Logan, Jeffrey Raymond Lozier, Henry McQuirter, Thomas K. Mundorf, Kenneth Olander, Richard J. Ou, Gregory J. Panzo, James H. Peace, Eugene E. Protzko, Robert Ritch, Kenneth Sall, Barry A. Schechter, Samuel Eric Seltzer, Pankajkumar G. Shah, Elizabeth Sharpe, Philip Lee Shettle, David G. Shulman, Inder Paul Singh, Stacy R. Smith, Stephen E. Smith, Robert John Smyth-Medina, Robert C. Sorenson, Richard Sturm, Gregory M. Sulkowski, James D. Sutton, Michael Tepedino, Julie Tsai, Carl B. Tubbs, David B. Tukel, Thomas Richard Walters, David L. Wirta
Publikováno v:
American Journal of Ophthalmology. 204:97-104
To compare the intraocular pressure (IOP)-lowering efficacy and safety of netarsudil once daily (QD) and timolol twice daily (BID).Double-masked, randomized, phase 3, noninferiority study.Patients with open-angle glaucoma or ocular hypertension (unme
Autor:
Jacob W, Brubaker, Savak, Teymoorian, Richard A, Lewis, Dale, Usner, Hayley J, McKee, Nancy, Ramirez, Casey C, Kopczynski, Theresa, Heah
Publikováno v:
Ophthalmology. Glaucoma. 3(5)
A phase 3 trial (MERCURY-1) investigated efficacy and safety of a once-daily, fixed-dose combination (FDC) of netarsudil and latanoprost, compared with each active component, in reducing elevated intraocular pressure (IOP) in patients with open-angle
Autor:
Richard A, Lewis, Brian, Levy, Nancy, Ramirez, Casey C, Kopczynski, Dale W, Usner, Gary D, Novack, David, Wirta
Publikováno v:
British Journal of Ophthalmology. 100:339-344
To evaluate the ocular hypotensive efficacy of fixed-dose combinations of the Rho kinase inhibitor and norepinephrine transport inhibitor AR-13324 (0.01% and 0.02%) and latanoprost (PG324 Ophthalmic Solution) relative to the active components AR-1332
Autor:
Scott Brockewell Shepard, Althea K. Alton, P. J. Kooh, Casey C. Kopczynski, K. Fechtel, Marc A. T. Muskavitch
Publikováno v:
Developmental genetics. 10(3)
Delta (Dl) is one of the six known zygotic neurogenic genes, each of which is essential for proper segregation of the embryonic ectoderm into neural and epidermal lineages. Molecular analysis of Dl reveals that it is a transcriptionally complex locus
Publikováno v:
Moleculargeneral genetics : MGG. 203(1)
Poly(A)4 RNA was isolated from maize scutella of different stages of post-germinative development and translated in vitro in a rabbit reticulocyte translation system. Immunoprecipitation of the translation products with CAT-2-specific antibody was us
Autor:
Sturdivant J; Research & Development, Aerie Pharmaceuticals, Inc., Durham, North Carolina, USA., Williams SS; Research & Development, Aerie Pharmaceuticals, Inc., Durham, North Carolina, USA., Ina M; Research & Development, Aerie Pharmaceuticals, Inc., Durham, North Carolina, USA., Weksler M; Research & Development, Aerie Pharmaceuticals, Inc., Durham, North Carolina, USA., McDougal A; Research & Development, Aerie Pharmaceuticals, Inc., Durham, North Carolina, USA., Clancy D; Research & Development, Aerie Pharmaceuticals, Inc., Durham, North Carolina, USA., deLong MA; Research & Development, Aerie Pharmaceuticals, Inc., Durham, North Carolina, USA., Girouard N; Research & Development, Aerie Pharmaceuticals, Inc., Durham, North Carolina, USA., Zaretskaia M; Research & Development, Aerie Pharmaceuticals, Inc., Durham, North Carolina, USA., Brennan K; Research & Development, Aerie Pharmaceuticals, Inc., Durham, North Carolina, USA., Glendenning A; Research & Development, Aerie Pharmaceuticals, Inc., Durham, North Carolina, USA., Foley B; Research & Development, Aerie Pharmaceuticals, Inc., Durham, North Carolina, USA., Lin CW; Research & Development, Aerie Pharmaceuticals, Inc., Durham, North Carolina, USA., White JC; Research & Development, Aerie Pharmaceuticals, Inc., Durham, North Carolina, USA., Kopczynski C; Research & Development, Aerie Pharmaceuticals, Inc., Durham, North Carolina, USA., Kelly CR; Research & Development, Aerie Pharmaceuticals, Inc., Durham, North Carolina, USA.
Publikováno v:
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics [J Ocul Pharmacol Ther] 2023 Mar; Vol. 39 (2), pp. 117-127. Date of Electronic Publication: 2023 Jan 04.
Autor:
Ren R; Boston University School of Medicine, Department of Ophthalmology, Boston, Massachusetts, United States., Humphrey AA; Boston University School of Medicine, Department of Ophthalmology, Boston, Massachusetts, United States., Kopczynski C; Aerie Pharmaceuticals, Inc., Durham, North Carolina, United States., Gong H; Boston University School of Medicine, Department of Ophthalmology, Boston, Massachusetts, United States.
Publikováno v:
Investigative ophthalmology & visual science [Invest Ophthalmol Vis Sci] 2023 Feb 01; Vol. 64 (2), pp. 7.
Autor:
Sit AJ; From the Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: sit.arthur@mayo.edu., Gupta D; Department of Ophthalmology, Duke University, Durham, North Carolina, USA., Kazemi A; From the Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA., McKee H; Aerie Pharmaceuticals, Inc., Durham, North Carolina, USA., Challa P; Department of Ophthalmology, Duke University, Durham, North Carolina, USA., Liu KC; Department of Ophthalmology, Duke University, Durham, North Carolina, USA., Lopez J; Aerie Pharmaceuticals, Inc., Durham, North Carolina, USA., Kopczynski C; Aerie Pharmaceuticals, Inc., Durham, North Carolina, USA., Heah T; Aerie Pharmaceuticals, Inc., Durham, North Carolina, USA.
Publikováno v:
American journal of ophthalmology [Am J Ophthalmol] 2021 Jun; Vol. 226, pp. 262-269. Date of Electronic Publication: 2021 Jan 29.